ALCON FDA Approval NDA 016968

NDA 016968

ALCON

FDA Drug Application

Application #016968

Documents

Letter2002-11-25
Letter2004-11-16
Label2002-11-25
Label2016-01-26
Letter2016-01-22
Label2004-11-16

Application Sponsors

NDA 016968ALCON

Marketing Status

Prescription001

Application Products

001SOLUTION;INTRAOCULAR0.01%1MIOSTATCARBACHOL

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1972-09-28PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1978-08-08PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1978-06-12PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1978-06-12PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1980-04-24PRIORITY
LABELING; LabelingSUPPL6AP1980-04-24
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1983-05-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1983-12-06PRIORITY
LABELING; LabelingSUPPL9AP1984-08-13
LABELING; LabelingSUPPL12AP1989-12-14
EFFICACY; EfficacySUPPL13AP1995-08-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1996-06-26PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1997-01-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1997-05-02PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1999-04-15PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1999-10-18PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2001-12-18PRIORITY
LABELING; LabelingSUPPL20AP2002-11-25STANDARD
LABELING; LabelingSUPPL22AP2004-11-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2015-02-23PRIORITY
LABELING; LabelingSUPPL29AP2016-01-21STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL8Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL28Null0
SUPPL29Null15

CDER Filings

ALCON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 16968
            [companyName] => ALCON
            [docInserts] => ["",""]
            [products] => [{"drugName":"MIOSTAT","activeIngredients":"CARBACHOL","strength":"0.01%","dosageForm":"SOLUTION;INTRAOCULAR","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"01\/21\/2016","submission":"SUPPL-29","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/016968s029lbl.pdf\"}]","notes":""},{"actionDate":"11\/10\/2004","submission":"SUPPL-22","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/16968s022lbl.pdf\"}]","notes":""},{"actionDate":"11\/25\/2002","submission":"SUPPL-20","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/16968slr020_Miostat_lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"MIOSTAT","submission":"CARBACHOL","actionType":"0.01%","submissionClassification":"SOLUTION;INTRAOCULAR","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2016-01-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.